Reimbursement
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Start-Up Spotlight: PneumoWave Hopes Sensor Tech Can Prevent Opioid Deaths
The Glaswegian company is tackling a tricky area of health care with its intelligent sensor and cloud processing technologies.
US Postal Service To Distribute Biden’s Free COVID-19 Rapid Antigen At-Home Tests Starting This Week
Americans can order up to four rapid antigen tests per household through the USPS website now, or a phone hotline soon. The administration is working to buy another half a billion tests in the near future.
JPM 2022: Abiomed, Penumbra, Renalityx
The annual J.P. Morgan Healthcare Conference includes presentations from major medtech companies describing their experience in 2021 and expectations for 2022 as they continue to cope with the impact of the Omicron surge. Here are some of the highlights from the presentations on the fourth day of the meeting.
Biden Pledges A Billion COVID-19 Tests, Announces Plan Requiring Private Insurers To Pay For At-Home Diagnostics
The Biden administration announced on 13 January that it’s purchasing an additional 500 million COVID-19 tests to be distributed free to any American wanting one, bringing the total to 1 billion tests procured.
Cardio Industry Puts Weight Behind UK Call For National CVD Strategy
Better uptake of medtech in tackling cardiovascular disease can bring benefits across the entire pathway of care, say UK CVD companies, who are urging the government to improve levels of technology adoption.
Telehealth Study Rates All 50 States On Patient Access To Virtual Care
Several US states hit hardest by COVID-19 have the most restrictive telehealth laws, according to a report from the Reason Foundation, Cicero Institute and Pioneer Institute. As telehealth becomes more integrated into the country’s health care system, states should adopt more reforms so residents can benefit from the advancing technology, the report urges.
Interview: What Does Breakthrough Designation Mean For Manus Neurodynamica?
Medtech Insight spoke to Rutger Zietsma, Manus Neurodynamica’ CEO, to learn about the next commercial steps for the company's Neuromotor Pen for differential diagnosis of neuromotor impairment.
MTI’s Top 21 Of ’21: Omicron, Remote Reg Assessments, QSR Delays, US Capitol Insurrection Make Headlines
What a doozy of a year 2021 was in the medical device space – capped on one end by a deadly insurrection blasted by medtech heavy-hitters, and on the other end by news that the COVID-19 Omicron variant is wreaking havoc on some diagnostics (and many US FDA on-site inspections). Here are Medtech Insight’s Top 21 US regulation, policy, quality control and compliance stories of 2021, as determined by reader interest.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.